Financhill
Back

Structure Therapeutics Vs. Pfizer Industry Stock Comparison

Sell
32

GPCR
Structure Therapeutics

Last Price:
33.44
Seasonality Move:
-14.82%
Sell
23

PFE
Pfizer

Last Price:
25.63
Seasonality Move:
2.08%
Sell
32
Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics a Buy, Sell or Hold?

  • The current Structure Therapeutics [GPCR] share price is $33.41. The Score for GPCR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • GPCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Pfizer (PFE) is a Sell

Is Pfizer a Buy, Sell or Hold?

  • The current Pfizer [PFE] share price is $25.65. The Score for PFE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • PFE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GPCR Stock Price Chart

What is Structure Therapeutics's stock price today?

  • The Structure Therapeutics share price today is $33.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

PFE Stock Price Chart

What is Pfizer's stock price today?

  • The Pfizer share price today is $25.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PFE is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.86 Sell
Relative Strength Index (14 RSI): 41.58 Sell
Chaikin Money Flow: 882035 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.2 - 39.9) Sell
Bollinger Bands (100): (35.54 - 41.32) Sell

PFE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.95 Sell
Relative Strength Index (14 RSI): 36.7 Sell
Chaikin Money Flow: 28876047 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.71 - 28.61) Sell
Bollinger Bands (100): (27.38 - 29.98) Sell

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.62 Sell
20-day SMA: 36.75 Sell
50-day SMA: 38.81 Sell
200-day SMA: 39.76 Sell
8-day EMA: 33.58 Sell
20-day EMA: 35.75 Sell
50-day EMA: 37.61 Sell
200-day EMA: 39.17 Sell

PFE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.4 Buy
20-day SMA: 26.76 Sell
50-day SMA: 28.21 Sell
200-day SMA: 28.09 Sell
8-day EMA: 25.54 Buy
20-day EMA: 26.48 Sell
50-day EMA: 27.63 Sell
200-day EMA: 28.91 Sell

Structure Therapeutics Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.15 per share.

Pfizer Earnings Growth & PFE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and a decrease next year of $0.03 per share.

Structure Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Pfizer Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):